Fungal infections should be part of the core outcome set for COVID-19

Affiliations

¹ Department of Medical Microbiology and Center of Expertise in Mycology Radboudumc/CWZ, Radboud University Medical Centre, Nijmegen, Netherlands. Electronic address: paul.verweij@radboudumc.nl.
² Mycology-Parasitology Department, Hôpital Saint-Louis, Molecular Mycology Unit, CNRS UMR2000, National Reference Centre for Invasive Mycoses and Antifungals, Institut Pasteur, Université de Paris, Paris, France.

Paul E Verweij et al. Lancet Infect Dis. 2021 Jun.

. 2021 Jun;21(6):e145.

doi: 10.1016/S1473-3099(20)30591-0. Epub 2020 Dec 7.

¹ Department of Medical Microbiology and Center of Expertise in Mycology Radboudumc/CWZ, Radboud University Medical Centre, Nijmegen, Netherlands. Electronic address: paul.verweij@radboudumc.nl.
² Mycology-Parasitology Department, Hôpital Saint-Louis, Molecular Mycology Unit, CNRS UMR2000, National Reference Centre for Invasive Mycoses and Antifungals, Institut Pasteur, Université de Paris, Paris, France.

No abstract available

Comment in

Fungal infections should be part of the core outcome set for COVID-19 - Authors' reply.
Marshall JC, Murthy S, Diaz J; WHO Working Group on the Clinical Characterisation and Management of COVID-19 infection. Marshall JC, et al. Lancet Infect Dis. 2021 Jun;21(6):e146. doi: 10.1016/S1473-3099(20)30681-2. Epub 2020 Dec 7. Lancet Infect Dis. 2021. PMID: 33301729 Free PMC article. No abstract available.

1. WHO Working Group on the Clinical Characterisation and Management of COVID-19 infection A minimal common outcome measure set for COVID-19 clinical research. Lancet Infect Dis. 2020;20:e192–e197. - PMC - PubMed
1. Alanio A, Dellière S, Fodil S, Bretagne S, Mégarbane B. Prevalence of putative invasive pulmonary aspergillosis in critically ill patients with COVID-19. Lancet Respir Med. 2020;8:e48–e49. - PMC - PubMed
1. Schauwvlieghe AFAD, Rijnders BJA, Philips N, et al. Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study. Lancet Respir Med. 2018;6:782–792. - PubMed
1. Nyga R, Maizel J, Nseir S, et al. Invasive tracheobronchial aspergillosis in critically ill patients with severe influenza. Am J Respir Crit Care Med. 2020 doi: 10.1164/rccm.201.910.1931OC. published online May 14. - DOI - PubMed
1. Verweij PE, Rijnders BJA, Brüggemann RJM, et al. Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion. Intensive Care Med. 2020 doi: 10.1007/s00134.020.06091-6. published online June 22. - DOI - PMC - PubMed